Share repurchase programme The share buy-back programme

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Share repurchase programme

The share buy-back programme runs from 27 January 2015 to 30 April 2015. In this period RTX will acquire shares with a value of up to DKK 3.0 million. The share buy-back programme is initiated and structured in compliance with the EU Commission Regulation No. 2273/2003 of 22 December 2003 (the so-called Safe Harbour Regulative for share buy-back programmes) which ensures that RTX is protected against violation of insider legislation in relation to the share buy-back programme.

Since the announcement as of 27 January 2015, the following transactions have been made under the program:  

  Number of shares Average purchase Price Transaction value in DKK
Accumulated, last announcement 33,781 79.21 2,675,698
24 April 2015 800 83.00 66,400
27 April 2015 800 82.00 65,600
28 April 2015 750 83.80 62,850
29 April 2015 750 84.50 63,375
30 April 2015 806 81.92 66,028
Accumulated under the programme 37,687 79.60 2,999,951

The share repurchase program announced has now been concluded.

With the transactions stated above, RTX A/S owns a total of 426,831 of treasury shares, corresponding to 4.72% of the share capital. The total amount of shares in the company is 9,044,011 including treasury shares.          

For further questions or information contact: CFO Jacob Vittrup, tlf. +45 6155 0510

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lauletta Birnbaum Earns Distinction in 2026 Chambers Guide

Updated Category News Views 209

Lauletta Birnbaum Recognized in the 2026 Chambers Spotlight Guide Lauletta Birnbaum has received prestigious recognition in the 2026 Chambers Spotlight Guide in the category of Corporate/Commercial Law. This honor highlights the firm's commitment to providing exceptional legal services to its clients. The Importance of Legal Recognition Chambers and Partners is recognized...

Continue Reading
Medicenna Therapeutics Showcases Advances in Cancer Treatment

Updated Category News Views 127

Medicenna Therapeutics Showcases Advances in Cancer Treatment Medicenna Therapeutics Corp. is making notable strides in the field of cancer immunotherapy. With a focus on developing innovative therapies, the company is gaining attention for its promising Superkines targeting a range of conditions, including cancer. One of their leading programs, MDNA11, has showcased...

Continue Reading
DÉKUPLE Reports Strong Growth in First-Half Earnings 2024

Updated Category News Views 258

DÉKUPLE reported its first-half earnings for 2024, showcasing an 8.8% rise in net sales, totaling €104.6 million. The figures signal a resilient company navigating a turbulent economic backdrop, but traders are already weighing the potential fallout. Key Financial Metrics: Profitability vs. Economic Headwinds The group's gross margin jumped 5.8%, hitting €83.5...

Continue Reading
Main Street Capital Corporation Declares 2025 Dividend Increases

Updated Category News Views 220

Regular Monthly Dividends Announced by Main Street Capital Main Street Capital Corporation (NYSE: MAIN) has taken a significant step forward in announcing its regular monthly dividends for the early part of 2025. The Board of Directors has declared a monthly dividend of $0.25 per share for January, February, and March of that year. This move showcases the company's...

Continue Reading
Exciting New Travel Offers Just for Travelzoo Club Members

Updated Category News Views 306

Exclusive Travel Offers for Club Members Travelzoo® (NASDAQ: TZOO), a leading platform for travel enthusiasts, has rolled out an enticing set of offers tailored specifically for its Club Members. These deals are meticulously negotiated to provide the best experiences at the most competitive prices. Whether you're looking for adventure or relaxation, there's something for...

Continue Reading